Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 6:14:2029-2049.
doi: 10.2147/TCRM.S138000. eCollection 2018.

A comprehensive overview on osteoporosis and its risk factors

Affiliations
Review

A comprehensive overview on osteoporosis and its risk factors

Farkhondeh Pouresmaeili et al. Ther Clin Risk Manag. .

Abstract

Osteoporosis is a bone disorder with remarkable changes in bone biologic material and consequent bone structural distraction, affecting millions of people around the world from different ethnic groups. Bone fragility is the worse outcome of the disease, which needs long term therapy and medical management, especially in the elderly. Many involved genes including environmental factors have been introduced as the disease risk factors so far, of which genes should be considered as effective early diagnosis biomarkers, especially for the individuals from high-risk families. In this review, a number of important criteria involved in osteoporosis are addressed and discussed.

Keywords: BMD; HPT; atherosclerosis; bone and hip fractures; bone mineral density; hyperparathyroidism.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Common osteoporosis risk factors involved in pathways associated with bone formation and osteoporotic fractures. Note: RA, smoking, glucocorticoids, diabetes mellitus and tumors, the most common risk factors, negatively control the bone organization pathway, resulting in osteoporotic fractures. Abbreviations: IL, interleukin; M-CSF, macrophage colony stimulating factor; OPG, osteoprotegerin; PPARγ, peroxisome proliferator-activated receptor-γ; PTH, parathyroid hormone; RA, rheumatoid arthritis; RANKL, RANK with its ligand; TNF, tumor necrosis factor; DM, diabetes mellitus; AP2, adipocyte fatty acid binding protein 2; RANK, receptor activator of nuclear factor κ.

References

    1. Bouillon R, Burckhardt P, Christiansen C, et al. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med. 1991;90:107–110. - PubMed
    1. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–1141. - PubMed
    1. Consensus N. Development panel on osteoporosis: prevention, diagnosis and therapy. JAMA. 2001;285:785–795. - PubMed
    1. Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22:671–685. - PubMed
    1. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194:S3–S11. - PubMed